Although several reasonable ways of targeting pStat3 function and several targeted inhibitors have been reported, the role of Stat3 in the pathogenesis of ovarian cancer has not been fully elucidated, and so far, no small molecular inhibitor of Stat3 has been prepared for clinical development. The gene discussed is STAT3; the disease is ovarian carcinoma.